Dr. Gottschlich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4260 Glendale Milford Rd
Suite 201
Cincinnati, OH 45242Phone+1 513-769-2762Fax+1 513-769-2769- Is this information wrong?
Education & Training
- Wake Forest University School of MedicineFellowship, Allergy and Immunology, 1986 - 1988
- Jewish Hospital of CincinnatiResidency, Internal Medicine, 1983 - 1985
- Wright State UniversityInternship, Internal Medicine, 1982 - 1983
- Ohio State University College of MedicineClass of 1982
Certifications & Licensure
- OH State Medical License 1983 - 2025
- SC State Medical License 2023 - 2024
- KY State Medical License 1989 - 2006
- NC State Medical License 1986 - 1990
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Clinical Trials
- Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD) Start of enrollment: 2008 Dec 01
- A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease Start of enrollment: 2011 Nov 01
- Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee Start of enrollment: 2014 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsCorrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared t...Donald P. Tashkin, Fernando J. Martinez, Roberto Rodriguez-Roisin, Charles Fogarty, Mark Gotfried, Michael Denenberg, Gregory Gottschlich, James F. Donohue, Chad Orevi...> ;Respiratory Medicine. 2017 Aug 1
- 82 citationsEfficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD.Martinez, F. J., Rabe, K. F., Ferguson, G. T., Fabbri, L. M., Rennard, S., Feldman, G. J., Sethi, S., Spangenthal, S., Gottschlich, G. M., Rodriguez-Roisin, R., Arora,...> ;Chest. 2016 Dec 6
- 18 citationsA multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocompon...Donald P. Tashkin, Fernando J. Martinez, Roberto Rodriguez-Roisin, Charles Fogarty, Mark Gotfried, Michael Denenberg, Gregory Gottschlich, James F. Donohue, Chad Orevi...> ;Respiratory Medicine. 2016 Nov 1
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
- The Jewish Hospital - Mercy HealthCincinnati, Ohio
- Bethesda North HospitalCincinnati, Ohio
- TriHealth Evendale HospitalCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: